版本:
中国

BRIEF-Crispr Therapeutics - Marc Becker, senior vice president, CFO will go on family, medical leave of absence, effective March 21, 2017,

March 20 Crispr Therapeutics AG:

* Crispr Therapeutics AG- effective March 21, 2017, Marc Becker, senior vice president and CFO will go on a family and medical leave of absence

* Crispr Therapeutics AG- currently plans to provide an update on status of Becker's leave of absence prior to end of q2 - sec filing

* Crispr Therapeutics AG- during Becker's leave of absence Samarth Kulkarni Co's chief business officer will serve as acting principal financial officer Source text (bit.ly/2mNH33R) Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐